EUVIMEDEUVIMED entdecken
Kohortenstudie

Preventive treatment status among adults presenting with status migrainosus: a retrospective emergency department cohort study

Shimrit Heiliczer, Galit Almoznino, Oved Daniel

Journal of Oral & Facial Pain and Headache · 12.11.2026

DOI: 10.22514/jofph.2026.077 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Oral & Facial Pain and Headache, online erschienen am 12.11.2026. Verfasst von Shimrit Heiliczer und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Status migrainosus (SM) is a disabling migraine complication that remains poorly characterized in emergency settings, particularly regarding prevention at presentation. We aimed to characterize documented preventive-treatment status among adults presenting to the emergency department (ED) with SM and explore associated baseline clinical characteristics.

Methods

We conducted a single-center retrospective cohort study of adults with International Classification of Headache Disorders, 3rd edition (ICHD-3)-defined SM between January 2017 and August 2025. The screening frame comprised 1426 migraine-coded ED discharges; all 19 SM-coded encounters and 187 predefined high-suspicion encounters underwent manual chart review. The first confirmed SM presentation was the index presentation. Between-group comparisons were exploratory, with Benjamini-Hochberg false discovery rate (FDR) correction across 24 comparisons as a sensitivity analysis.

Results

Forty-two patients met ICHD-3 criteria and accounted for 65 SM-related ED presentations. At index presentation, 10/42 (23.8%; exact 95% confidence interval 12.1–39.5%) had documented ongoing preventive therapy and 32/42 (76.2%) did not. Patients presenting despite preventive therapy had nominally higher rates of chronic migraine (62.5% vs. 10.0%, p = 0.009), anxiety disorders (40.0% vs. 6.2%, p = 0.021), chronic pain comorbidity (30.0% vs. 3.1%, p = 0.036), selective serotonin reuptake inhibitor use (40.0% vs. 6.5%, p = 0.024), and cannabis use (33.3% vs. 3.4%, p = 0.035). None remained significant after FDR correction (minimum q = 0.174).

Conclusions

Most identified patients with ICHD-3-confirmed SM in this cohort were not receiving documented migraine preventive therapy. Exploratory secondary analyses identified nominal differences in several baseline clinical characteristics according to preventive-treatment status, but none remained significant after FDR correction. These findings provide a rationale for prospective investigation of the clinical significance of preventive-treatment status in SM, including whether SM occurring without prevention identifies an opportunity for preventive reassessment and whether SM occurring during prevention reflects underlying disease burden, treatment-related factors, or true preventive-treatment failure.

Zitieren

APA

Heiliczer, S., Almoznino, G., & Daniel, O. (2026). Preventive treatment status among adults presenting with status migrainosus: a retrospective emergency department cohort study. Journal of Oral & Facial Pain and Headache. https://doi.org/10.22514/jofph.2026.077

Vancouver

Heiliczer S, Almoznino G, Daniel O. Preventive treatment status among adults presenting with status migrainosus: a retrospective emergency department cohort study. Journal of Oral & Facial Pain and Headache. 2026. doi:10.22514/jofph.2026.077

BibTeX
@article{Heiliczer2026,
  author = {Heiliczer, Shimrit and Almoznino, Galit and Daniel, Oved},
  title = {Preventive treatment status among adults presenting with status migrainosus: a retrospective emergency department cohort study},
  journal = {Journal of Oral & Facial Pain and Headache},
  year = {2026},
  doi = {10.22514/jofph.2026.077}
}
Kostenlos starten →